Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PT010 vs PT009 in Moderate to Very Severe COPD
NCT03081247Phase 3Withdrawn
- Sponsor
- Pearl Therapeutics
- Start
- Apr 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Breztri Aerosphere in chronic obstructive pulmonary disease (COPD), sponsored by Pearl Therapeutics. Planned start Apr 2018; status: withdrawn.
02
Drugs
Breztri Aerosphere
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03081247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03081247.